UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vanguard Morningstar Value ETF
VTV
$188B
| $2.24B | 0.41% |
13,221,827
+225,726
| +2% | +$39.6M |
|
27
AbbVie
ABBV
$455B
| $2.24B | 0.41% |
12,580,208
+1,086,102
| +9% | +$200M |
|
28
Procter & Gamble
PG
$335B
| $2.18B | 0.4% |
13,008,586
+164,259
| +1% | +$28M |
|
29
Chevron
CVX
$383B
| $2.1B | 0.39% |
14,530,520
+4,403,232
| +43% | +$674M |
|
30
Vanguard S&P 500 ETF
VOO
$972B
| $2.07B | 0.38% |
3,847,453
+426,055
| +12% | +$231M |
|
31
ExxonMobil
XOM
$651B
| $2.07B | 0.38% |
19,257,277
+2,247,242
| +13% | +$263M |
|
32
PUT
Invesco QQQ Trust
QQQ
$450B
| $2.06B | 0.38% |
4,023,800
-4,213,437
| -51% | -$2.13B |
|
33
Johnson & Johnson
JNJ
$617B
| $2.02B | 0.37% |
13,989,917
+2,388,470
| +21% | +$370M |
|
|
34
Advanced Micro Devices
AMD
$791B
| $1.91B | 0.35% |
15,845,691
+5,594,129
| +55% | +$805M |
|
35
Mastercard
MA
$510B
| $1.89B | 0.35% |
3,585,595
-12,178
| -0.3% | -$6.3M |
|
36
Walmart Inc
WMT
$884B
| $1.88B | 0.35% |
20,758,255
+2,302,106
| +12% | +$200M |
|
37
McDonald's
MCD
$191B
| $1.85B | 0.34% |
6,376,658
+640,790
| +11% | +$191M |
|
38
Salesforce
CRM
$148B
| $1.84B | 0.34% |
5,515,723
-93,796
| -2% | -$29.9M |
|
39
Cisco
CSCO
$448B
| $1.81B | 0.33% |
30,536,839
+1,670,743
| +6% | +$95.4M |
|
40
CALL
NVIDIA
NVDA
$4.72T
| $1.77B | 0.33% |
13,155,223
-4,131,389
| -24% | -$569M |
|
41
Merck
MRK
$321B
| $1.72B | 0.32% |
17,271,289
+1,964,947
| +13% | +$203M |
|
42
iShares Core MSCI EAFE ETF
IEFA
$192B
| $1.72B | 0.32% |
24,421,382
+665,390
| +3% | +$49.1M |
|
43
TSMC
TSM
$2.09T
| $1.72B | 0.32% |
8,686,374
+1,561,237
| +22% | +$302M |
|
44
Coca-Cola
KO
$381B
| $1.61B | 0.3% |
25,832,723
+1,365,992
| +6% | +$89.2M |
|
45
Oracle
ORCL
$367B
| $1.57B | 0.29% |
9,393,641
+1,478,129
| +19% | +$263M |
|
46
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $1.54B | 0.29% |
36,926,200
+8,232,100
| +29% | +$365M |
|
47
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $1.53B | 0.28% |
19,506,400
+10,145,200
| +108% | +$805M |
|
48
NextEra Energy
NEE
$183B
| $1.5B | 0.28% |
20,975,306
+2,839,495
| +16% | +$221M |
|
49
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $1.48B | 0.27% |
23,740,948
-974,652
| -4% | -$62.5M |
|
50
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $1.47B | 0.27% |
22,250,620
+270,452
| +1% | +$18.4M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.